Peter Milner is listed as an executive officer and director on 13 SEC Form D filings by 3 issuers between Nov 2009 and Aug 2020: Retrotope, Inc. (Los Altos, CA — biotechnology — 2016–2020; $25.5M reported sold to 66 investors), Armetheon, Inc. (Menlo Park, CA — biotechnology — 2014–2015; $24.4M reported sold to 32 investors) and ARYx Therapeutics, Inc. (Fremont, CA — pharmaceuticals — 2009; $2.01M reported sold to 7 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 11 years. Across those companies the filings report $51.9M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 13 public filings for Peter Milner and found 9 differences, 1 worth asking the sponsor about: Peter Milner is no longer listed on the Dec 15, 2020 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.